News & Updates

As a first-line antiseizure medication (ASM) for infants, levetiracetam (LEV) is potentially noninferior to phenobarbital (PB) and shows a more acceptable safety profile, a new study has found.

Adolescent boys with high body mass index (BMI) are highly likely to develop early-onset atrial fibrillation (AF) with subsequently worse clinical outcomes, including all-cause mortality, heart failure, and stroke, according to a study.

There appears to be evidence suggesting that hyperbaric oxygen therapy does not yield motor and cognitive benefits in children with cerebral palsy, a recent study has found.

Smartphone-based real-life activity data can be used to track physical performance in patients after lumbar spine surgery for degenerative lumbar disorders (DLD), according to a recent study.

In infants born with extremely low birth weight (ELBW), parenteral nutrition supplement using a mixed lipid emulsion containing fish oil does not result in neurodevelopmental or behavioural benefits at preschool age, a new study has found.

Treatment with fenfluramine produces sustained reductions in drop seizure frequency, especially generalized tonic-clonic seizures, in patients with Lennox-Gastaut syndrome (LGS), according to the results of an open-label extension trial.

A novel thrombectomy device using a sequestered approach delivers positive clinical outcomes in the treatment of high-risk, large-volume deep vein thrombosis (DVT), according to a study.